Neurotrope Inc. | Key People and Executives
Joshua N. Silverman
Chairman
Charles S. Ryan
Chief Executive Officer & Director
George L. Perry
Independent Director
Bruce Todd Bernstein
Director
James Gottlieb
Independent Director
William S. Singer
Vice Chairman
Joshua N. Silverman
Chairman
Charles S. Ryan
Chief Executive Officer & Director
Daniel Alkon
President & Chief Scientific Officer
Robert Weinstein
CFO, Secretary, Treasurer & Executive VP
Shana Kay Phares
Director
Jeffrey Benison
Director-Communications
George L. Perry
Independent Director
Bruce Todd Bernstein
Independent Director
James R. Gottlieb
Independent Director
William S. Singer
Vice Chairman
| Address |
205 East 42nd Street
New York New York 10017
United States
|
|
Employees
|
- |
| Website |
http://www.neurotropebioscience.com |
| Updated |
07/08/2019 |
| Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. It operates through the following geographical segments: US; European Union; Japan; and China and India. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. |
